Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Classical hematology 1

Conditions

Nasopharyngeal Carcinoma 1Anemia, Iron-Deficiency 1Anemia 1

Interventions

Epoetin Alfa 10Darbepoetin alfa 8ferric carboxymaltose 7fludarabine 4Cyclophosphamide 4Busulfan 4Blood Transfusion 4fludarabine phosphate 3Filgrastim 3Erythrocyte Transfusion 3Cyclosporine 3Biopsy 3Antilymphocyte Serum 3thymoglobulin 2ruxolitinib 2iron isomaltoside 1000 2ferrous sulfate 2ferrous fumarate 2ferric gluconate 2Vitamin B 12 2Thiotepa 2Therapeutics 2Taxes 2Surveys and Questionnaires 2Peripheral Blood Stem Cell Transplantation 2Methotrexate 2Lenalidomide 2Folic Acid 2Ferric Oxide, Saccharated 2Carboplatin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Anemia × Niferex × Clear all
NCT05913414 2023-06-22

Iron Isomaltide for Iron-deficiency Anemia Patients With Locally Advanced Nasopharyngeal Carcinoma

Sun Yat-sen University

Phase 2 Unknown
120 enrolled
Classical hematologyHead & Neck

Nasopharyngeal Carcinoma, Anemia, Anemia, Iron-Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡